November 9, 2015 by Geoff Walden and Chain Drug Review
Adam Fein, Alex Gourlay, chain drug retailing, CVS/pharmacy, Drug Channels Institute, George Fairweather, John Standley, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2015, Issue 11-09-2015, Issues, News
DEERFIELD, Ill. — The consolidation of chain drug retailing climaxed last month with Walgreens Boots Alliance Inc.’s (WBA’s) acquisition of Rite Aid Corp. In the largest outright purchase of a chain in the industry’s history, WBA agreed to acquire Rite Aid for $9 per share, or $17.2 billion, including debt. The price represents a premium
November 9, 2015 by David Pinto and Chain Drug Review
Caremark, chain drug retailing, CVS, drug store retailing, Rite Aid, Walgreens, Walgreens Boots Alliance
2015, Issue 11-09-2015, Issues, Opinion
The spectacular is becoming so commonplace that even the most astonishing events in chain drug retailing are assuming a ho-hum characteristic. Nothing new here, even if Walgreens has announced its intention to acquire Rite Aid. Put another way, America’s largest chain drug retailer is intent on combining its fortunes and its future with the country’s
October 12, 2015 by David Pinto and Chain Drug Review
Alex Gourlay, chain drug retailing, CVS Health, David Pinto, Helena Foulkes, John Standley, Ken Martindale, Larry Merlo, Ornella Barra, Rite Aid, Walgreens, Walgreens Boots Alliance
2015, Issue 10-12-2015, Issues, Opinion
As the year 2015 winds down, the chain drug community must face the reality that the coming year will be unlike any that has preceded it. The same drug chains still rule the U.S. landscape. But the content of their character and the face of the people who guide them are vastly different than in
February 2, 2015 by David Pinto and Chain Drug Review
chain drug industry, chain drug retailers, chain drug retailing, chain drug stores, David Pinto, drug chains, merchandising, new products, product selection
2015, Issue 02-02-2015, Opinion
A small group of chain drug industry veterans met recently in Cleveland to discuss the lamentable state of innovative and creative merchandising in chain drug retailing these days. The group, consisting of some dozen retailers, suppliers and association executives, concluded that a variety of factors — most notably industry consolidation and the tendency among retailers
January 19, 2015 by David Pinto and Chain Drug Review
2015 NACDS Regional Chain Conference, Annual Meeting, chain drug retailing, David Pinto, John Standley, NACDS, NACDS meetings, National Association of Chain Drug Stores, regional drug chains, Rite Aid, Total Store Expo
Issue 01-19-2015, Opinion
The cataclysmic changes within the chain drug retailing community, whatever their ultimate implications for America’s largest drug chains and for the industry in general, are putting the country’s regional drug chains more glaringly in the spotlight. Indeed, not only are America’s smaller drug chains more professionally managed and operated than they have yet been, they
January 5, 2015 by David Pinto and Chain Drug Review
Alliance Boots, AmerisourceBergen, Bartell Drugs, Cardinal Health, chain drug industry, chain drug retailing, CVS Health, David Pinto, Greg Wasson, Kerr Drug, National Association of Chain Drug Stores, Rite Aid, Tony Civello, Walgreens, Walgreens Boots Alliance
2015, Issue 01-05-2015, Opinion
Which events were most significant for chain drug retailing in 2014? As usual, that is not an easy question to answer. In many ways, 2014 was a remarkable year for the chain drug industry, one in which the character of the business was changed, probably irrevocably. The industry assumed a global character for perhaps the